Role of Nitric Oxide Synthases in the Infarct Size-Reducing Effect Conferred by Heat Stress in Isolated Rat Hearts
This study provides the first demonstration of the
implication of NO in the heat stress-induced delayed cardioprotection. We
observed that prior heat stress significantly reduced infarct size in the
isolated rat heart subjected to an ischaemia-reperfusion sequence, in
accordance with previous studies (Donnelly et
al, 1992; Marber et al, 1993; Joyeux
et al, 1997). This myocardial
ischaemic tolerance was abolished by the administration of both L-NAME and L-NIL prior to
heat stress. The use of both inhibitors
allowed the investigation of the role of the different NOS isoforms. While L-NAME
is unselective, L-NIL is a selective inhibitor of iNOS (Moore et al., 1994). In our study, the
treatment applied had to satisfy two points. First, NOS isoforms had to be
inhibited at the moment of heat stress. This point has been assessed by
Schwartz and co-workers (1997). They have demonstrated that following similar L-NAME
and L-NIL treatment, corresponding NOS isoforms were inhibited since
LPS-induced hypotension was corrected. By the same manner, LPS-induced increase
in both urinary excretion of nitrates-nitrites and cGMP level was abolished
(Schwartz et al., 1997; Lortie et al., 2000). Secondly,
treatments had to be reversible since in this study we have investigated the
role of NO as a trigger of the heat stress-induced cardioprotection and not as
a mediator during the ischaemia-reperfusion sequence. We have previously
verified this point in vivo in the rat (Lagneux et al., 2000). This study showed that 24 h after the end of
treatment, mean arterial blood pressure of anaesthetised rats was within the
normal range, and that the hypotension induced by bradykinin, which is
triggered by NO production (Davisson et al., 1996), was comparable to
that of control animals.
It seems that HS induces NO production, since Malyshev
and co-workers (1995) have observed a sharp transient increase in NO generation
1 h after HS in different organs of the rat and notably the myocardium. Our
study shows that the non-selective NOS inhibitor, L-NAME, completely
abolished the HS-induced protection against myocardial infarction in rat heart.
Thus, NO formation seems to play an essential role in this cardioprotective
phenomenon. We also demonstrate that the selective iNOS inhibitor, L-NIL,
is as effective as L-NAME, providing the first evidence that NO
produced by iNOS is involved in HS-induced cardioprotection.
NO has also
been shown to be involved in other cardioprotective phenomena. Indeed, Bolli’s
group has recently presented convincing evidence that NO is a trigger of the
delayed protection conferred by ischaemic preconditioning in the conscious
rabbit (Bolli et al., 1998).
Pretreatment with a NOS inhibitor during the initial ischaemic stimulus blocked
protection (Qiu et al., 1997), and
conversely a NO donor in lieu of ischaemia induced delayed cardioprotection
(Takano et al., 1998; Banerjee et al., 1999). Moreover, iNOS seems to
be the principal NOS isoform involved in this cardioprotective phenomenon,
since a selective iNOS inhibitor completely abolished the delayed protection
induced by the ischaemic preconditioning in
vivo in the rabbit (Imagawa et al.,
1999). This is in accordance with a study from Guo and co-workers (1999) which
demonstrates in vivo in the mouse
that the late phase of ischaemic preconditioning is associated with a selective
up-regulation of myocardial iNOS. NO seems also trigger the delayed protective
effect of monophosphoryl lipid A (MLA) in the isolated rat heart, since
co-administration of NOS inhibitors and MLA abolished the preservation of
ventricular function induced by MLA alone (Tosaki et al., 1998; György et al.,
1999).
Our immunohistochemical analysis showed an increase in
myocardial HSP 27 and 72 synthesis induced 24 hours after heat stress, which
was not modified by the blockade of all NOS isoforms. It seems thus that the
heat stress-induced cardioprotection does not appear to be related to induction
of HSP 27 and 72 synthesis, since pretreatment with L-NAME abolished
myocardial ischemic tolerance while it had no effect on the increase in
myocardial HSP levels. Several studies point to a relation between HSP 27 and
72 induction and cardioprotection. Hence, Marber and co-workers (1993) have
observed that prior hyperthermia induces a high level of myocardial HSP 72
expression along with the enhanced myocardial tolerance to ischaemic injury.
Moreover, the level of HSP 72 has been directly correlated to the degree of
heat stress-induced cardioprotection in the rat (Hutter et al., 1994) and in the rabbit (Marber et al., 1994). Furthermore, improved functional recovery or reduced
infarct size has been observed in transgenic mouse and rat hearts
overexpressing HSP 72 and subjected to an ischaemia-reperfusion sequence
(Marber et al., 1995; Plumier et al., 1995; Hutter et al., 1996; Suzuki et al., 1997). By the same manner, it
has been shown that the overexpression of HSP 27 or 72 protects rat
cardiomyocytes against ischaemic insult (Martin et al., 1997; Mestril et al.,
1996).
Our study shows that protection of myocardium can be
blocked independently of the level of HSP 27 and 72 induction. This finding is
in agreement with previous studies showing that protein kinase C (PKC)
inhibition or a1-adrenoceptor blockade
abolished the cardioprotection conferred by heat stress with no effect on
myocardial HSP 72 synthesis (Joyeux et al.,
1997 and 1998a). One possible explanation is that NOS inhibition, as PKC
inhibition or a1-adrenoceptor blockade, could
alter the phosphorylation and/or the functional state of HSPs thus rendering
them ineffective in protecting the myocardium. Further experiments are required
to explore this hypothesis.
Although HSPs are widely studied as primary effectors
of heat stress-induced protection, other mediators can be evoked (Joyeux et al., 1999). Hence, ATP-sensitive
potassium (KATP) channel opening appears to mediate the heat
stress-induced delayed cardioprotection in the rat (Joyeux et al., 1998b) and in the rabbit (Hoag et al., 1997; Pell et al.,
1997). Moreover, some physiological effects of NO seem to be due to the KATP
channel activation. For example, peripheral vascular vasodilatory response have
been found to involve specific KATP channels (Champion &
Kadowitz, 1997) and it seems that NO could potentiate the KATP channel
current in isolated guinea-pig ventricular cells (Shinbo & Iijima, 1997). A
recent study on rabbit ventricular myocytes suggests that NO could act directly
as a mitochondrial KATP channel opener (Sasaki et al., 2000). Furthermore, it has been observed that KATP
channel blockers abolish the ability of the NO donor to protect cultured
myocytes against ischaemic injury (Stambaugh et al., 1999). Thus, it could be hypothesised that the NO-dependant
opening of KATP channels mediates HS-induced cardioprotection.
In summary, this study provides the first
demonstration of the implication of NO as trigger of resistance to myocardial
infarction induced by heat stress in the isolated rat heart, since both L-NAME
and L-NIL pretreatments abolished the heat stress-induced
cardioprotection. Although iNOS appears to play a role in this cardioprotective
phenomenon, the role of the other isoforms remains to be determined. Finally,
NO appears to mediate this cardioprotection by a mechanism independent of HSP
27 and 72 induction. Further investigations are required to clarify the signal
transduction pathways which co-ordinate the heat stress response and the
potential role of HSP 27 and 72, and of other stress-inducible proteins, in
mediating adaptative cytoprotection.
Post Comment
No comments